Solubility Data as a Response for a Challenge for Formulation Chemists: Imidazolium-Based Ionic Liquids and Antitubercular Antibiotic Medicines Faria, R.A.M.; Vieira, T.F.M.; Melo, C.I.; Bogel-Łukasik, E.; Journal of Chemical & Engineering Data 2016, 61, 3116-3126
Data
P = 101 kPa
x (mol mol-1) TSLE (K)
0.0263 279.98
0.1836 352.93
0.1901 354.24
0.1954 355.26
0.2012 356.37
0.2158 358.99
0.2236 360.33
0.2475 364.13
0.2670 366.98
0.2903 370.12
0.3274 374.63
0.0313 286.5
0.3475 376.86
0.4011 382.25
0.4275 384.64
0.4835 389.26
0.5009 390.58
0.5247 392.33
0.5380 393.26
0.5566 394.54
0.5636 395.01
0.5909 396.78
0.0368 292.62
0.6278 399.05
0.6910 402.65
0.7247 404.44
0.7583 406.14
0.7689 406.66
0.8234 409.23
0.8890 412.11
1 461.42
0.0645 313.68
0.0888 325.66
0.1196 336.83
0.1509 345.57
0.1697 349.98
0.1737 350.85
1394; pyrazinamide + 1-butyl-3-methylimidazolium hexafluorophosphate; 00481:00485